可选商品即将上架
NovexisKLOW
THB 0
选择规格
—
OVERVIEW
KLOW (CU50 + TB10 + BC10 + KPV10) (80mg/vial)
This research formulation combines GHK-CU, TB-500, BPC-157, and KPV for advanced studies involving tissue repair, inflammation modulation, and regenerative signaling pathways.
OVERVIEW
KLOW (CU50 + TB10 + BC10 + KPV10) (80mg/vial)
This research formulation combines GHK-CU, TB-500, BPC-157, and KPV for advanced studies involving tissue repair, inflammation modulation, and regenerative signaling pathways.
TYPICAL RESEARCH DOSING
Typical research administration: 2–6mg total blend, 2–4 times weekly depending on experimental design.
PRIMARY RESEARCH APPLICATION
- Regenerative medicine models
- Anti-inflammatory pathway research
- Tissue remodeling studies
- Recovery and repair synergy investigations
KEY RESEARCH BENEFITS
- Multi-pathway regenerative support
- Investigated for inflammatory cytokine modulation
- Supports skin and connective tissue research
- May enhance cellular recovery signaling studies